about
Pericentrin expression in Down's syndrome.Leucine zipper, down regulated in cancer-1 gene expression in prostate cancer.Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients.Cerebellar degeneration-related autoantigen 1 (CDR1) gene expression in prostate cancer cell lines.A polymorphism (rs1042522) in TP53 gene is a risk factor for Down Syndrome in Sicilian mothers.Arterial erectile dysfunction: different severities of endothelial apoptosis between diabetic patients "responders" and "non responders" to sildenafil.Killer-specific secretory (Ksp37) gene expression in subjects with Down's syndrome.Accuracy of 3 Tesla pelvic phased-array multiparametric MRI in diagnosing prostate cancer at repeat biopsy.Relationship of semen hyperviscosity with IL-6, TNF-α, IL-10 and ROS production in seminal plasma of infertile patients with prostatitis and prostato-vesiculitis.LDOC1 gene expression in two patients with head and neck squamous cell carcinomas and Parkinson's disease.SPAG5 mRNA is over-expressed in peripheral blood leukocytes of patients with Down's syndrome and cryptorchidism.CASP3 protein expression by flow cytometry in Down's syndrome subjects.Decreased miRNA expression in Klinefelter syndrome.Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.Expression of SPANX proteins in human-ejaculated spermatozoa and sperm precursors.Reduced mitochondrial mRNA expression in dementia with Lewy bodies.SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Down's syndrome subjects with undescended testes.A new 6-bp SOX-3 polyalanine tract deletion does not segregate with mental retardation.The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.Expression of Phosphodiesterase 4B cAMP-Specific Gene in Subjects With Cryptorchidism and Down's Syndrome.KIF21A mRNA expression in patients with Down syndrome.NF-kB1 gene expression in Down syndrome patients.Gene expression profiling and qRT-PCR expression of RRP1B, PCNT, KIF21A and ADRB2 in leucocytes of Down's syndrome subjects.PARP-1 and CASP3 genes are up-regulated in LNCaP and PC-3 prostate cancer cell lines.A high percentage of skin melanoma cells expresses SPANX proteins.Differential expression of PARP1 mRNA in leucocytes of patients with Down's syndrome.Poly (ADP-ribose) polymerase-1 (PARP-1) -410C/T polymorphism in Sicilian patients with Parkinson's disease.SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Sicilian patients with melanoma.LDOC1 Gene Expression in Men With Klinefelter Syndrome.Cerebellar degeneration-related autoantigen 1 (CDR1) gene expression in Alzheimer's disease.CASP3 and LDOC-1 gene expression in a patient with carcinoma in the hairy part of the head skin and Alzheimer disease.Three apoptotic genes are upregulated in a patient with Alzheimer's disease and well-differentiated squamous cell carcinoma.Gene expression profiling and qRT-PCR expression of RRP1B, PCNT, KIF21A and ADRB2 in leucocytes of Down’s syndrome subjectsEvidence for long noncoding RNA GAS5 up-regulationin patients with Klinefelter syndromeImmunoexpression of SPANX-C in metastatic uveal melanomaOver expression of LDOC1 and PARP1, two pro-apoptotic genes, in a patient with cryptorchidism and DiGeorge anomalyPARP1 and CASP3 gene expression in a patient with multiple head and neck squamous cell carcinoma and Parkinson diseaseHyperviscosity of semen in patients with male accessory gland infection:direct measurement with quantitative viscosimeterTwo proapoptotic genes are downregulated in a patient with melanoma and repeated in-transit metastasesMitochondrial mRNA expression in fibroblasts of Down syndrome subjects
P50
Q34366882-C2C3E9D1-19A0-48C9-A605-F8B4E7AD960CQ37288264-FB8DB8CC-D60A-4E7B-9246-FC2E5B9654BBQ37839571-DAB5561B-2041-4920-A27E-0774C8B5CBB3Q39040306-709CE075-A4DD-4B59-BF86-002B3B820503Q39183131-F8855D21-2567-4F20-BDF6-5E663291043EQ39477583-7F73B0B5-9150-481F-92EE-E02B16FF09D0Q39874454-C78F6BDA-889A-49C1-8FFD-72D5E853CD8FQ40254061-5B4CFB1F-B1BA-477A-8C8E-74F82A5A2EF3Q42450806-D2902010-75B9-48A0-8D77-F271A721AB36Q42510013-A14BEF76-8ABC-4C95-BEC1-187851FF619FQ45179723-F4BFFBE2-6804-42F8-8EE5-BD6960F8D358Q46545035-099A1BA6-0E65-4105-AEE6-FAB1B9112CFCQ47109614-1339A91F-A7B4-42BC-88AF-27ABB195AF21Q47135887-5377BD05-D68A-4227-9053-176004DB8095Q47614750-A3C35E69-5C7A-4D1D-A4D7-70FA5EC57203Q47629677-FC0E7676-CE55-4935-9201-53D00EE1C333Q47874665-4D4C6ED1-6B2F-401C-8815-46C4117F734CQ48107115-29633753-7FCD-4D9E-B495-40BB79A90AB8Q48169958-82D3FEF8-15A8-4ED0-BEF4-755041084E9CQ48240486-90B49165-AE2B-4634-B269-F964B1815738Q48380879-471F2213-FFC9-4906-A300-3AD567A04153Q48484246-FBD57830-295B-4151-9EDD-EB156CD52BDAQ48535645-77A7D064-33D9-4B74-B8D0-49A575B149BCQ48652705-BD2D04EE-4185-4441-B75C-8FE4E9848B5DQ48690829-C97E6736-DB6D-4FB0-98E8-62161797F330Q48722378-6CFB1F69-1652-478D-A613-55447F687615Q48820785-B351D99D-B46B-42DD-BCB5-CB3EB4AEAAE5Q49085041-F0D7883C-8587-4D72-A4AB-2364E97CB9DEQ50532496-73713DAD-1E58-44A8-9874-0F35E39FF5EAQ50646415-B58C98C8-C6E6-48C6-9944-F4C899098C18Q50899901-F3C7E19C-4BEB-4961-9EA8-592BBF9F4EE6Q50969640-7F21258D-1EFA-4F2E-A4E2-5DA91F1A47E6Q57720147-7D963BD8-1D36-401A-8407-23872A816DA5Q60918761-4263F91E-2509-4B41-BE64-F00EBB8962C2Q64039341-C433A799-EC44-4869-A67F-5465A01B2B0DQ84049619-4FF71E1B-1CF5-4993-9C0C-62F4A3DD0910Q84281586-A374F695-DCC0-41D3-B79B-74D15C61AC1DQ84947488-CC74C5F2-C1D5-4B7A-80B9-21226EA45FD8Q85070317-1B7D5D3D-9601-4814-B87E-B960E328AA1AQ87949881-1DD6361A-898D-49F9-B26B-78BB0234F3C8
P50
description
researcher ORCID ID = 0000-0003-1075-8993
@en
wetenschapper
@nl
name
MICHELE SALEMI
@ast
MICHELE SALEMI
@en
MICHELE SALEMI
@es
MICHELE SALEMI
@nl
type
label
MICHELE SALEMI
@ast
MICHELE SALEMI
@en
MICHELE SALEMI
@es
MICHELE SALEMI
@nl
prefLabel
MICHELE SALEMI
@ast
MICHELE SALEMI
@en
MICHELE SALEMI
@es
MICHELE SALEMI
@nl
P1153
7004151605
P31
P496
0000-0003-1075-8993